The FDA granted Seres Therapeutics’ SER-287 orphan drug designation. SER-287 treats pediatric ulcerative colitis.
The FDA approved Ferring Pharmaceutical’s Clenpiq, a low-volume colonoscopy prep solution.
Takeda appointed Toshio Fujimoto, MD, to serve as the general manager of the Health Innovation Park in Shonan, Japan.
More articles on gastroenterology:
GI leader to know: Dr. Essam Quraishi of Gastrointestinal & Liver Consultants
Stock market week-in-review for 5 large GI companies — Nov. 27 to Dec. 1
How AI is improving polyp detection
